Editorial: Local Immunotherapy: A Way to Convert Tumors From "Cold" to "Hot"

Epigenetic plus cytokine therapy induces stem-like CD8+ T-cell reservoirs and intratumoral immune niches to overcome anti-PD-1 resistance.

Journal for immunotherapy of cancer·2026

The Molecular and Immunological Landscape in Nasopharyngeal Carcinoma (NPC) Differs by Somatostatin Receptor 2 (SSTR2) Expression.

Cancer medicine·2026

Erratum to 'Clinical and Immunologic Features of Primary Enteric-Type Thymic Adenocarcinomas: A Rare Variant of a Rare Cancer' [JTO Clinical and Research Reports 7 (2026) 101019].

JTO clinical and research reports·2026

Bi-directional support of T lymphoma and a lymphoma-associated monocyte population involving Notch signaling in mice.

Oncoimmunology·2026

Durable responses to triplet immunotherapy targeting TGF-β, PD-L1, and tumor antigen, with an IL-15 receptor superagonist in mismatch repair proficient castration-resistant prostate cancer.

Journal for immunotherapy of cancer·2026

Clinical and Immunologic Features of Primary Enteric-Type Thymic Adenocarcinomas: A Rare Variant of a Rare Cancer.

JTO clinical and research reports·2026

Expansion of the world health organization (WHO) gastric neuroendocrine tumor classification: introducing types 4 and 5.

Journal of the National Cancer Institute·2026

Opioid limiting law and opioid prescriptions among Medicaid-enrolled survivors of childhood cancer.

Journal of the National Cancer Institute·2026

Ancestry-Dependent Immunologic and Prognostic Effects Characterize the Prostate Cancer Urinary Proteome.

Journal of the National Cancer Institute·2026

SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis.

Journal of the National Cancer Institute·2026

PRO‑CTCAE in Oncology Drug Evaluation: Cross-Agency Review of Regulatory and Health Technology Assessment Decision-Making in the United States and Europe.

Journal of the National Cancer Institute·2026

Endocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer Prevention.

Journal of the National Cancer Institute·2026

The spatial architecture of tumor immunity: Emerging predictive biomarkers across cancer.

Immunologic research·2026

Inflammatory Soft Tissue Tumors: A Wolf in Sheep's Clothing.

Archives of pathology & laboratory medicine·2026

Usefulness of 20-mm incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma: a single-center experience.

Leukemia & lymphoma·2026

ITPRIPL1: A tumor immune-associated biomarker with prognostic and therapeutic implications in gastrointestinal cancer.

Scientific reports·2026

Differential effects of BCG-Russia and BCG-TICE on trained immunity: Potential implications for bladder cancer immunotherapy.

PloS one·2026

Spatial statistics infer structured immune signatures in primary prostate cancer.

Cancer immunology research·2026

Related Experiment Videos

Editorial: Local Immunotherapy: A Way to Convert Tumors From "Cold" to "Hot"

Related Concept Videos

Epigenetic plus cytokine therapy induces stem-like CD8+ T-cell reservoirs and intratumoral immune niches to overcome anti-PD-1 resistance.

The Molecular and Immunological Landscape in Nasopharyngeal Carcinoma (NPC) Differs by Somatostatin Receptor 2 (SSTR2) Expression.

Erratum to 'Clinical and Immunologic Features of Primary Enteric-Type Thymic Adenocarcinomas: A Rare Variant of a Rare Cancer' [JTO Clinical and Research Reports 7 (2026) 101019].

Bi-directional support of T lymphoma and a lymphoma-associated monocyte population involving Notch signaling in mice.

Durable responses to triplet immunotherapy targeting TGF-β, PD-L1, and tumor antigen, with an IL-15 receptor superagonist in mismatch repair proficient castration-resistant prostate cancer.

Clinical and Immunologic Features of Primary Enteric-Type Thymic Adenocarcinomas: A Rare Variant of a Rare Cancer.

Expansion of the world health organization (WHO) gastric neuroendocrine tumor classification: introducing types 4 and 5.

Opioid limiting law and opioid prescriptions among Medicaid-enrolled survivors of childhood cancer.

Ancestry-Dependent Immunologic and Prognostic Effects Characterize the Prostate Cancer Urinary Proteome.

SHBG as a breast cancer risk biomarker in premenopausal women? Results from an individual patient's pooled analysis and a meta-analysis.

PRO‑CTCAE in Oncology Drug Evaluation: Cross-Agency Review of Regulatory and Health Technology Assessment Decision-Making in the United States and Europe.

Endocrine Biomarker Changes in a Randomised Low-Dose Tamoxifen Trial for Breast Cancer Prevention.

The spatial architecture of tumor immunity: Emerging predictive biomarkers across cancer.

Inflammatory Soft Tissue Tumors: A Wolf in Sheep's Clothing.

Usefulness of 20-mm incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma: a single-center experience.

ITPRIPL1: A tumor immune-associated biomarker with prognostic and therapeutic implications in gastrointestinal cancer.

Differential effects of BCG-Russia and BCG-TICE on trained immunity: Potential implications for bladder cancer immunotherapy.

Spatial statistics infer structured immune signatures in primary prostate cancer.

Related Experiment Videos

Editorial: Local Immunotherapy: A Way to Convert Tumors From "Cold" to "Hot"

Related Concept Videos

Related Articles